X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2447) 2447
Book Chapter (39) 39
Dissertation (8) 8
Magazine Article (4) 4
Conference Proceeding (3) 3
Publication (3) 3
Reference (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alemtuzumab (2358) 2358
humans (2026) 2026
science & technology (1828) 1828
life sciences & biomedicine (1817) 1817
antibodies, monoclonal, humanized (1139) 1139
male (985) 985
female (937) 937
antibodies, monoclonal - therapeutic use (883) 883
middle aged (790) 790
adult (762) 762
antibodies, neoplasm - therapeutic use (744) 744
hematology (670) 670
transplantation (593) 593
treatment outcome (543) 543
antineoplastic agents - therapeutic use (476) 476
aged (471) 471
oncology (449) 449
immunosuppressive agents - therapeutic use (413) 413
immunology (399) 399
antibodies, monoclonal, humanized - therapeutic use (396) 396
rituximab (392) 392
multiple sclerosis (388) 388
monoclonal antibodies (328) 328
leukemia, lymphocytic, chronic, b-cell - drug therapy (320) 320
antibodies, monoclonal - adverse effects (297) 297
antibodies, monoclonal - administration & dosage (283) 283
antibodies, neoplasm - adverse effects (268) 268
antibodies, neoplasm - administration & dosage (258) 258
surgery (250) 250
adolescent (248) 248
animals (228) 228
neurosciences & neurology (222) 222
retrospective studies (216) 216
cd52 antigen (214) 214
clinical neurology (214) 214
abridged index medicus (212) 212
antineoplastic combined chemotherapy protocols - therapeutic use (205) 205
vidarabine - analogs & derivatives (203) 203
transplantation, homologous (197) 197
immunotherapy (191) 191
care and treatment (188) 188
risk factors (185) 185
follow-up studies (179) 179
health aspects (178) 178
drug therapy (172) 172
young adult (167) 167
transplantation conditioning - methods (166) 166
chronic lymphocytic leukemia (159) 159
antibodies, monoclonal, murine-derived (158) 158
graft rejection - prevention & control (157) 157
antibodies, monoclonal, humanized - administration & dosage (153) 153
antineoplastic agents - adverse effects (151) 151
kidney transplantation (149) 149
stem cells (148) 148
child (147) 147
multiple sclerosis - drug therapy (147) 147
t cells (146) 146
research (142) 142
antigens, cd - immunology (139) 139
medicine & public health (137) 137
antineoplastic agents - administration & dosage (136) 136
clinical trials as topic (136) 136
graft vs host disease - prevention & control (135) 135
recurrence (135) 135
time factors (135) 135
antibodies, monoclonal - pharmacology (134) 134
hematopoietic stem cell transplantation (134) 134
antibodies, monoclonal, humanized - adverse effects (133) 133
pharmacology & pharmacy (131) 131
immunosuppression (129) 129
remission induction (126) 126
immunosuppressive agents - adverse effects (121) 121
multiple sclerosis, relapsing-remitting - drug therapy (121) 121
antineoplastic agents (118) 118
hematology, oncology and palliative medicine (116) 116
kidneys (116) 116
graft survival (115) 115
antibodies, neoplasm - pharmacology (114) 114
stem cell transplantation (114) 114
hematopoietic stem cells (112) 112
glycoproteins - immunology (111) 111
campath-1h (110) 110
antigens, neoplasm - immunology (109) 109
neurosciences (109) 109
aged, 80 and over (108) 108
t-lymphocytes - immunology (108) 108
natalizumab (107) 107
survival analysis (107) 107
antibodies, monoclonal - immunology (106) 106
antimitotic agents (106) 106
antilymphocyte serum - therapeutic use (105) 105
alemtuzumab - therapeutic use (104) 104
survival rate (104) 104
vidarabine - administration & dosage (104) 104
disease-free survival (103) 103
leukemia (103) 103
cancer (102) 102
immunologic factors - therapeutic use (102) 102
hematopoietic stem cell transplantation - adverse effects (99) 99
kidney transplantation - immunology (98) 98
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2357) 2357
German (40) 40
French (36) 36
Spanish (22) 22
Japanese (17) 17
Russian (17) 17
Polish (12) 12
Czech (10) 10
Chinese (9) 9
Hungarian (8) 8
Italian (3) 3
Norwegian (3) 3
Portuguese (3) 3
Danish (2) 2
Korean (2) 2
Swedish (2) 2
Bosnian (1) 1
Dutch (1) 1
Finnish (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Therapeutic advances in neurological disorders, ISSN 1756-2864, 08/2017, Volume 10, Issue 10, pp. 343 - 359
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2019, Volume 321, Issue 2, pp. 175 - 187
Journal Article
Journal of neurology, ISSN 1432-1459, 11/2018, Volume 266, Issue 1, pp. 165 - 173
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 4, pp. 635 - 641
Journal Article
Actas Dermo-Sifiliograficas, ISSN 0001-7310, 09/2015, Volume 106, Issue 7, pp. e33 - e39
Alemtuzumab is a monoclonal antibody that has been used to treat refractory cases of Sézary syndrome (SS) and advanced mycosis fungoides. We present 5 patients... 
Sézary syndrome | Treatment | Alemtuzumab
Journal Article
American journal of transplantation, ISSN 1600-6135, 06/2018, Volume 18, Issue 6, pp. 1424 - 1434
Calcineurin inhibitors (CNIs, eg, tacrolimus) reduce short‐term kidney transplant failure, but chronic nephrotoxicity may contribute to late transplant loss.... 
immunosuppressant ‐ calcineurin inhibitor (CNI) | immunosuppressant ‐ fusion proteins and monoclonal antibodies: alemtuzumab | immunosuppressant ‐ mechanistic target of rapamycin (mTOR) | immunosuppression/immune modulation | clinical research/practice | kidney transplantation/nephrology | immunosuppressant ‐ fusion proteins and monoclonal antibodies: basiliximab/daclizumab | immunosuppressant - mechanistic target of rapamycin (mTOR) | immunosuppressant - calcineurin inhibitor (CNI) | immunosuppressant - fusion proteins and monoclonal antibodies: basiliximab/daclizumab | immunosuppressant - fusion proteins and monoclonal antibodies: alemtuzumab | Transplantation | Life Sciences & Biomedicine | Surgery | Science & Technology | Kidney Diseases - physiopathology | Calcineurin Inhibitors - adverse effects | Glomerular Filtration Rate | Humans | Middle Aged | Kidney Diseases - chemically induced | Adult | Female | Immunosuppressive Agents - adverse effects | Male | Alemtuzumab - pharmacology | Transplantation, Homologous - adverse effects | Proteins | Tacrolimus | Clinical trials | Transplantation of organs, tissues, etc | Monoclonal antibodies | Product development | Research | Kidney diseases | Health aspects | Index Medicus | practice | ORIGINAL ARTICLES | kidney transplantation | immunosuppression | immunosuppressant ‐ fusion proteins and monoclonal antibodies: basiliximab | nephrology | clinical research | immune modulation | Original | daclizumab
Journal Article
Journal Article